We only have this paper's title and publication details.
Read it at the sourceSGLT2 inhibitors show potential benefits in heart failure treatment, indicating they may help patients beyond just controlling blood sugar levels.
Not applicable
No takes yet. Share an insight, caveat, or question.
Emman Memon (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: